chartexchange

Novocure denied FDA approval for metastatic cancer treatment

MedTech Dive | Nov 9, 2026 11:40 AM EST

The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

Read original article